drugset / Trial / NCT04791228
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a pilot study of LTLD with MR-HIFU hyperthermia followed by ablation in subjects with refractory/relapsed solid tumors.
Timeline
- Start
- 2022-11-10
- Primary completion
- 2024-12-23
- Completion
- 2024-12-23
Outcome
Outcome not reported
Stopped (Enrollment): “Low enrollment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lyso-thermosensitive Liposomal Doxorubicin | Unknown | 50 mg/m2 | Intravenous |